Ratio Therapeutics
MA - BostonBiotechnology
Focus: Ratio Therapeutics is an oncology-focused radiotherapeutics biotech company headquartered in Boston developing targeted alpha and radioisotope-based therapies for solid tumors.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
5+2 this month
Stable — net +2 jobs in 30d
5 added, 3 removed. Backfill posture.
Should You Work at Ratio Therapeutics?
AI assessmentBest suited for early-career scientists seeking deep technical expertise in radiotherapeutics; higher risk due to lack of financial transparency and limited scale.
Why Work Here
- Focused pipeline in radiotherapeutics, an emerging modality with fewer competitors than traditional small molecules or antibodies
- Opportunity to contribute to Phase 1 programs in high-unmet-need areas (soft tissue sarcoma, prostate cancer)
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
[Ac 225]RTX-2358
Advanced Soft Tissue SarcomaClinical Trials (1)
NCT07156565Actinium Therapy for Late-stage Aggressive Sarcomas
Phase 1Help build intelligence for Ratio Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.